Display options
Share it on

Photodermatol Photoimmunol Photomed. 2021 Jul;37(4):306-312. doi: 10.1111/phpp.12653. Epub 2021 Jan 16.

Oxidative stress and the cholinergic system in non-segmental vitiligo: Effect of narrow band ultraviolet b.

Photodermatology, photoimmunology & photomedicine

Eman Raafat Said, Noha Abd El Rahim Nagui, Laila Ahmed Rashed, Wedad Zoheir Mostafa

Affiliations

  1. Dermatology Department, Faculty of medicine, Cairo University, Cairo, Egypt.
  2. Biochemistry Department, Faculty of Medicine, Cairo University, Cairo, Egypt.

PMID: 33404131 DOI: 10.1111/phpp.12653

Abstract

BACKGROUND: Despite exhaustive research, melanocyte disappearance and the evolution of vitiligo remain enigmatic, and although multi-factorial, oxidative stress appears as a major player. The role of cutaneous cholinergic system in vitiligo pathogenesis has also been reported in some studies.

OBJECTIVE: To evaluate and correlate the influence of phototherapy on cutaneous cholinergic system and oxidative stress in vitiligo.

METHODS: Acetyl choline (ACh), its receptors; nicotinic (nAChR) and muscarinic (mAChR); acetylcholine esterase (AChE) and H

RESULTS: Mean ACh and H

CONCLUSION: Cholinergic system is strongly involved in vitiligo pathogenesis through H

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Keywords: NB-UVB; acetyl choline; acetyl choline esterase; acetyl choline receptors; hydrogen peroxide

References

  1. Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386(9988):74-84. - PubMed
  2. Schallreuter KU, Elwary S. Hydrogen peroxide regulates the cholinergic signal in a concentration dependent manner. Life Sci. 2007;80:2221-2226. - PubMed
  3. Kurzen H, Schallreuter KU. Novel aspects in cutaneous biology of acetylcholine synthesis and acetylcholine receptors. Exp Dermatol. 2004;13:27-30. - PubMed
  4. Chaichalotornkul S, Udompataikul M, Showpittapornchai U, Palungwachira P, Pradidarcheep W. Altered distribution of M2 and M4 muscarinic receptor expression in vitiligo. J Dermatol. 2011;38(5):493-497. - PubMed
  5. Wallace AB. The exposure and treatment of burns. Lancet. 1951;1(6653):501-504. - PubMed
  6. Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H. Parametric modeling of narrowband UVB phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol. 2004;140:677-683. - PubMed
  7. Abu Zeid O, Abdel-Aziz A, Rashed LA, Said ER. Role of the cutaneous extraneuronal cholinergic system in the pathogenesis of psoriasis: a case-control study. Clin Exp Dermatol. 2020;45(4):432-437. - PubMed
  8. Grando SA. Cholinergic control of epidermal cohesion. Exp Dermatol. 2006;15(4):265-282. - PubMed
  9. Gauthier Y, Surleve-Bazeille JE, Brunet M, Tamarelle C, Gauthier O, Texier L. Lowered tissue acetylcholinesterase activity: Possible etiology of vitiligo. [Article in French]. Nouv Presse Med. 1976;5(41):2806-2807. - PubMed
  10. Iyengar B. Modulation of melanocytic activity by acetylcholine. Acta Anat. 1989;136(2):139-141. - PubMed
  11. Elwary SM, Headley K, Schallreuter KU. Calcium homeostasis influences epidermal sweating in patients with vitiligo. Br J Dermatol. 1997;137(1):81-85. - PubMed
  12. Taieb A. Intrinsic and extrinsic pathomechanisms in vitiligo. Pigment Cell Res. 2000;13(suppl 8):41-47. - PubMed
  13. Schallreuter KU, Elwary SM, Gibbons NC, Rokos H, Wood JM. Activation/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun. 2004;315(2):502-508. - PubMed
  14. Mark MR, Domino EF, Han SS, Ortiz A, Mathews BN, Tait SK. Effect of parasympathetic denervation on acetylcholine levels in the rat parotid gland. Is there an extraneuronal pool of acetylcholine? Life Sci. 1983;33:1191-1197. - PubMed
  15. Wessler I, Kilbinger H, Bittinger F, Unger R, Kirkpatrick CJ. The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci. 2003;72:2055-2061. - PubMed
  16. Ndoye A, Buchli R, Greenberg B, et al. Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes in human epidermis. J Invest Dermatol. 1998;111(3):410-416. - PubMed
  17. Buchli R, Ndoye A, Grando S. Molecular characterization and immunolocalization of muscarinic and nicotinic acetylcholine receptors in human MCs. J Invest Dermatol. 1999;112:541. - PubMed
  18. Buchli R, Ndoye A, Arredondo J, Webber RJ, Grando SA. Identification and characterization of muscarinic acetylcholine receptor subtypes expressed in human skin melanocytes. Mol Cell Biochem. 2001;228:57-72. - PubMed
  19. Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol. 1991;97(6):1081-1085. - PubMed
  20. Yildirim MI, Baysal V, Inaloz HS, Kesici D, Delibas N. The role of oxidants and antioxidants in generalized vitiligo. J Dermatol. 2003;30(2):104-108. - PubMed
  21. Ines D, Sonia B, Riadh BM, et al. A comparative study of oxidant-antioxidant status in stable and active vitiligo patients. Arch Dermatol Res. 2006;298(4):147-152. - PubMed
  22. Arican O, Kurutas EB. Oxidative stress in the blood of patients with active localized vitiligo. Acta Dermatovenerol Alp Panonica Adriat. 2008;17(1):12-16. - PubMed
  23. Shajil EM, Begum R. Antioxidant status of segmental and nonsegmental vitiligo. Pigment Cell Res. 2006;19(2):179-180. - PubMed
  24. Schallreuter KU, Gibbons NC, Elwary SM, Parkin SM, Wood JM. Calcium-activated butyrylcholinesterase in human skin protects acetylcholinesterase against suicide inhibition by neurotoxic organophosphates. Biochem Biophys Res Commun. 2007;355(4):1069-1074. - PubMed
  25. Ali SA, Meitei KV. Nigella sativa seed extract and its bioactive compound thymoquinone: the new melanogens causing hyperpigmentation in the wall lizard melanophores. J Pharm Pharmacol. 2011;63(5):741-746. - PubMed
  26. Curtis BJ, Radek KA. Cholinergic Regulation of Keratinocyte Innate Immunity and Permeability Barrier Integrity: New Perspectives in Epidermal Immunity and Disease. J Invest Dermatol. 2012;132(1):28-42. - PubMed
  27. Nakamagoe K, Furuta J, Shioya A, Tamaoka A. A case of vitiligo vulgaris showing a pronounced improvement after treatment for myasthenia gravis. BMJ Case Rep. 2009; 2009:bcr07. - PubMed
  28. Tzartos SJ, Barkas T, Cung MT, et al. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol Rev. 1998;163:89-120. - PubMed
  29. De D, Kanwar AJ, Saikia UN, Jindal R. Colocalization of mucosal vitiligo and oral pemphigus vulgaris. Indian J Dermatol Venereol Leprol. 2012;78(1):111-113. - PubMed

Publication Types

Grant support